| 000 | 02631 a2200697 4500 | ||
|---|---|---|---|
| 005 | 20250515222804.0 | ||
| 264 | 0 | _c20100712 | |
| 008 | 201007s 0 0 eng d | ||
| 022 | _a1524-4636 | ||
| 024 | 7 |
_a10.1161/ATVBAHA.110.206425 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOeseburg, Hisko | |
| 245 | 0 | 0 |
_aGlucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A. _h[electronic resource] |
| 260 |
_bArteriosclerosis, thrombosis, and vascular biology _cJul 2010 |
||
| 300 |
_a1407-14 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdamantane _xanalogs & derivatives |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCellular Senescence _xdrug effects |
| 650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
| 650 | 0 | 4 |
_aCyclic AMP Response Element-Binding Protein _xmetabolism |
| 650 | 0 | 4 |
_aCyclic AMP-Dependent Protein Kinases _xmetabolism |
| 650 | 0 | 4 | _aDNA Damage |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xdrug therapy |
| 650 | 0 | 4 |
_aDipeptidyl-Peptidase IV Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 | _aExenatide |
| 650 | 0 | 4 |
_aGlucagon-Like Peptide 1 _xmetabolism |
| 650 | 0 | 4 | _aGlucagon-Like Peptide-1 Receptor |
| 650 | 0 | 4 |
_aHeme Oxygenase-1 _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrogen Peroxide _xpharmacology |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNAD(P)H Dehydrogenase (Quinone) _xmetabolism |
| 650 | 0 | 4 |
_aNitriles _xpharmacology |
| 650 | 0 | 4 |
_aOxidants _xpharmacology |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 |
_aPeptides _xpharmacology |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
| 650 | 0 | 4 |
_aPyrrolidines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Zucker |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Glucagon _xmetabolism |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aVenoms _xpharmacology |
| 650 | 0 | 4 | _aVildagliptin |
| 700 | 1 | _ade Boer, Rudolf A | |
| 700 | 1 | _aBuikema, Hendrik | |
| 700 | 1 | _avan der Harst, Pim | |
| 700 | 1 | _avan Gilst, Wiek H | |
| 700 | 1 | _aSilljé, Herman H W | |
| 773 | 0 |
_tArteriosclerosis, thrombosis, and vascular biology _gvol. 30 _gno. 7 _gp. 1407-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/ATVBAHA.110.206425 _zAvailable from publisher's website |
| 999 |
_c19803900 _d19803900 |
||